Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas
Stopped Withdrawal of pharmaceutical company support for the investigational drug
Conditions
- Brain and Central Nervous System Tumors
Interventions
- BIOLOGICAL: cintredekin besudotox
- PROCEDURE: conventional surgery
Sponsor
Pediatric Brain Tumor Consortium
Collaborators